JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.59% |
| 2 | Technology | 12.2% |
| 3 | Healthcare | 9.44% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CATM
2401
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $6.17M | ﹤0.01% |
333,276
-29,376
| -8% | -$588K |
|
2402
Unitil
UTL
$992M
| $6.17M | ﹤0.01% |
135,201
-2,053
| -1% | -$103K |
|
|
SGYP
2403
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $6.16M | ﹤0.01% |
2,763,538
-641,839
| -19% | -$1.6M |
|
|
CRZO
2404
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $6.15M | ﹤0.01% |
289,105
+286,361
| +10,436% | +$5.29M |
|
|
SRCL
2405
DELISTED
Stericycle Inc
SRCL
| $6.14M | ﹤0.01% |
90,278
-58,794
| -39% | -$3.99M |
|
2406
iShares Silver Trust
SLV
$31.3B
| $6.13M | ﹤0.01% |
383,662
-141,447
| -27% | -$2.23M |
|
|
AIMT
2407
DELISTED
Aimmune Therapeutics
AIMT
| $6.11M | ﹤0.01% |
161,609
-132,796
| -45% | -$4.28M |
|
|
ESND
2408
DELISTED
Essendant Inc.
ESND
| $6.11M | ﹤0.01% |
659,230
-57,385
| -8% | -$590K |
|
|
FSP
2409
Franklin Street Properties
FSP
$46.4M
| $6.11M | ﹤0.01% |
568,534
+180,442
| +46% | +$1.9M |
|
|
EGL
2410
DELISTED
Engility Holdings, Inc.
EGL
| $6.11M | ﹤0.01% |
215,163
-3,832
| -2% | -$117K |
|
2411
Vanguard S&P 500 Growth ETF
VOOG
$27.4B
| $6.09M | ﹤0.01% |
266,976
+265,176
| +14,732% | +$5.93M |
|
2412
Sabre
SABR
$892M
| $6.08M | ﹤0.01% |
296,499
+231,373
| +355% | +$4.43M |
|
2413
PUT
Aflac
AFL
$60.7B
| $6.07M | ﹤0.01% |
138,400
-160,000
| -54% | -$6.83M |
|
2414
AutoNation
AN
$6.89B
| $6.07M | ﹤0.01% |
118,307
+58,336
| +97% | +$2.96M |
|
|
JSD
2415
DELISTED
NUVEEN SHORT DURATION CREDIT OPPORTUNITIES FUND
JSD
| $6.07M | ﹤0.01% |
365,119
+6,631
| +2% | +$113K |
|
2416
SouthState Bank Corp
SSB
$10.8B
| $6.06M | ﹤0.01% |
69,502
+17,498
| +34% | +$1.57M |
|
2417
CALL
Teradyne
TER
$64.2B
| $6.05M | ﹤0.01% |
144,600
| – | – |
|
2418
Vanguard Short-Term Corporate Bond ETF
VCSH
$45.1B
| $6.05M | ﹤0.01% |
76,306
+32,049
| +72% | +$2.55M |
|
|
KL
2419
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $6.05M | ﹤0.01% |
393,836
-20,573
| -5% | -$283K |
|
|
CVGW
2420
DELISTED
Calavo Growers
CVGW
| $6.05M | ﹤0.01% |
71,668
+19,655
| +38% | +$1.45M |
|
2421
Check Point Software Technologies
CHKP
$13.7B
| $6.04M | ﹤0.01% |
58,348
-397,598
| -87% | -$43.2M |
|
2422
iShares MSCI ACWI ex US ETF
ACWX
$12B
| $6.04M | ﹤0.01% |
120,830
-22,881
| -16% | -$1.13M |
|
2423
Seacoast Banking Corp of Florida
SBCF
$3.48B
| $6.03M | ﹤0.01% |
239,065
+40,445
| +20% | +$1.01M |
|
2424
CALL
Lumen
LUMN
$6.6B
| $6.03M | ﹤0.01% |
361,200
-22,800
| -6% | -$387K |
|
2425
Innoviva
INVA
$1.5B
| $6.01M | ﹤0.01% |
423,630
-356,916
| -46% | -$4.76M |
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 811 new, 2,514 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 811 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.